Risk Factors for Symptomatic SARS-CoV2 Infection, Severe COVID-19, and Vaccination Response in the Severe Asthma Research Program
D21. TRANSLATIONAL COVID-19 STUDIES | May 1, 2023 | Volume: No volume available | Issue: No issue available | Pages: A6286-A6286
10.1164/ajrccm-conference.2023.207.1_meetingabstracts.a6286